Register a trial

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT06283017




Registration number
NCT06283017
Ethics application status
Date submitted
13/02/2024
Date registered
28/02/2024

Titles & IDs
Public title
Evaluation of the Effects of Hypoglossal Nerve Stimulation in Humans With Obstructive Sleep Apnea
Scientific title
Acute Proof-of-Concept Study to Evaluate Hypoglossal Nerve Stimulation in Humans With Obstructive Sleep Apnea
Secondary ID [1] 0 0
IM-002
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Sleep Apnea 0 0
Sleep Apnea, Obstructive 0 0
Sleep Disorder 0 0
Sleep Apnea Syndromes 0 0
Condition category
Condition code
Respiratory 0 0 0 0
Sleep apnoea
Neurological 0 0 0 0
Other neurological disorders
Mental Health 0 0 0 0
Other mental health disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Devices - Hypoglossal nerve stimulation

Experimental: Hypoglossal nerve stimulation - Device-mediated stimulation of the hypoglossal nerve


Treatment: Devices: Hypoglossal nerve stimulation
Device stimulation of the hypoglossal nerve
Intervention code [1] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Target identification and access outcomes
Timepoint [1] 0 0
Day 0
Primary outcome [2] 0 0
Tongue protrusion outcomes
Timepoint [2] 0 0
Day 0
Primary outcome [3] 0 0
Characterization of lead placement outcomes
Timepoint [3] 0 0
Day 0
Primary outcome [4] 0 0
Lead placement and removal outcomes
Timepoint [4] 0 0
Day 0
Primary outcome [5] 0 0
Safety outcomes
Timepoint [5] 0 0
Day 30

Eligibility
Key inclusion criteria
Subject must be eligible for a diagnostic or surgical procedure and

* Suffers from OSA (apnea/hypopnea index >10 event/h sleep) based on history and a physical exam.
* Is a surgical candidate.
* Is willing and capable of providing informed consent.
* Is willing to have a representative electrode array temporarily placed in the submandibular and mylohyoid space.
* Is willing to participate in the designated follow-up visits.
* Must be in good general health.
* Is able to understand and has voluntarily signed and dated the IRB or EC approved informed consent form (ICF) prior to initiation of any screening or study-specific procedure.
* Must be minimum of 18 years and maximum 80 years of age.
Minimum age
18 Years
Maximum age
80 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Has Body Mass Index above 35 kg/m2.
* Has had surgical resection or radiation therapy for cancer or congenital malformations in the larynx, tongue, or throat.
* Has significant co-morbidities making them unable or inappropriate to participate in this POC study.

Study design
Purpose of the study
Other
Allocation to intervention
NA
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
NA
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Active, not recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/06/2022
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
1/03/2024
Actual
Sample size
Target
Accrual to date
Final
14
Recruitment in Australia
Recruitment state(s)
SA
Recruitment hospital [1] 0 0
Adelaide Institute for Sleep Health, Flinders University - Adelaide
Recruitment postcode(s) [1] 0 0
5042 - Adelaide

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Invicta Medical Inc.
Address
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
Adelaide Institute for Sleep Health, Flinders University
Address [1] 0 0
Country [1] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.


Results not provided in https://clinicaltrials.gov/study/NCT06283017